Midkine expression by stem-like tumor cells drives persistence to mTOR inhibition and an immune-suppressive microenvironment
The tumour microenvironment in mTORC1 hyperactive cancers remains poorly characterised. Here, integrative analysis in tuberous sclerosis complex tumours with mTORC1 hyperactivity suggests distinct cell states associated with rapamycin resistance and immune modulation.
Main Authors: | Yan Tang, David J. Kwiatkowski, Elizabeth P. Henske |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2022-08-01
|
Series: | Nature Communications |
Online Access: | https://doi.org/10.1038/s41467-022-32673-7 |
Similar Items
-
Escaping mTOR inhibition for cancer therapy: Tumor suppressor functions of mTOR
by: Victor H. Villar, et al.
Published: (2017-05-01) -
mTOR inhibition attenuates chemosensitivity through the induction of chemotherapy resistant persisters
by: Yuanhui Liu, et al.
Published: (2022-11-01) -
Differential Reponses of Hematopoietic Stem and Progenitor Cells to mTOR Inhibition
by: Aimin Yang, et al.
Published: (2015-01-01) -
AAA + ATPase Thorase inhibits mTOR signaling through the disassembly of the mTOR complex 1
by: George K. E. Umanah, et al.
Published: (2022-08-01) -
The effects of mTOR inhibition in ischemic stroke
by: Schneider, AM
Published: (2022)